Lindoshil 25mg Capsule

Lenalidomide belongs to a class of medications known as immunomodulatory agents, which work through multiple mechanisms, including enhancing the immune system's ability to recognize and attack cancer cells, as well as directly interfering with the growth and survival of certain cancerous cells. It is commonly used in the treatment of multiple myeloma, a cancer affecting plasma cells in the bone marrow, often as part of a combination treatment regimen alongside other medications like dexamethasone. Lenalidomide is also used to treat certain types of lymphoma and myelodysplastic syndromes, conditions involving abnormal blood cell production. Additionally, it has anti-angiogenic properties, meaning it helps limit the formation of new blood vessels that tumors rely on for growth and nourishment. The medication is taken orally, with dosing carefully individualized based on the specific condition, treatment phase, and the patient's overall health and kidney function. Regular monitoring, including blood counts, is an essential part of treatment to help track the body's response and guide any necessary adjustments. Many patients experience meaningful disease control and improved outcomes as part of a comprehensive treatment plan involving Lenalidomide. Ongoing follow-up with an experienced oncology or hematology care team supports the best possible treatment results. As with all specialized cancer therapies, Lenalidomide capsules should be used strictly under the guidance of a healthcare provider experienced in treating the specific condition.